- Home
- PBYI vs FAX Comparison
PBYI vs FAX Comparison
Compare PBYI & FAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBYI | FAX |
|---|---|---|
| Founded | 2010 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.1M | 532.5M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | PBYI | FAX |
|---|---|---|
| Price | $8.22 | $12.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 410.6K | 214.6K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.09% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $27,685,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.33 | N/A |
| P/E Ratio | $105.13 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.76 | $12.57 |
| 52 Week High | $11.50 | $16.37 |
Technical Indicators
Market Signals| Indicator | PBYI | FAX |
|---|---|---|
| Relative Strength Index (RSI) | 30.69 | 48.72 |
| Support Level | $7.64 | $12.59 |
| Resistance Level | $8.53 | $12.99 |
| Average True Range (ATR) | 0.53 | 0.16 |
| MACD | -0.33 | 0.07 |
| Stochastic Oscillator | 14.61 | 63.72 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About FAX abrdn Asia-Pacific Income Fund Inc.
Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities and others.